National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01BA01	EBETREXAT	G	Methotrexate - 50mg/5ml	50mg/5ml	Injectable solution	1,507,821 L.L
A11DB	NEUROBION	B	Vitamin B12 - 1000mcg, Vitamin B6 - 100mg, Vitamin B1 - 100mg		Injectable solution	287,582 L.L
B03XA01	EPOMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4000UI/ml	4000UI/ml	Injectable solution	1,243,054 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	141,349 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
A11DB	NEURORUBINE	G	Vitamin B12 - 1mg, Vitamin B6 - 100mg, Vitamin B1 - 100mg		Injectable solution	302,365 L.L
B03XA01	EPOTEX 4000 BENTA	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable solution	1,209,458 L.L
B05XA03	CHLORURE DE SODIUM 0.9 pour cent Renaudin	G	Sodium chloride - 0.9%	0.9%	Injectable solution	385,683 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L04AB04	HUMIRA	BioTech	Adalimumab - 40mg/0.4ml	40mg/0.4ml	Injectable solution	L.L
B03XA01	EPOTEX 4000 BENTA	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU	4,000IU	Injectable solution	5,488,046 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	1,104,639 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	91,457,321 L.L
N05AF05	CLOPIXOL DEPOT	B	Zuclopenthixol decanoate - 200mg/ml	200mg/ml	Injectable solution	512,004 L.L
A10AE04	BASAGLAR KWIKPEN	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	4,114,846 L.L
B03XA01	EPREX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/0.4ml	4,000IU/0.4ml	Injectable solution	15,187,737 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	705,517 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	179,063,666 L.L
N05AF05	CLOPIXOL ACUPHASE	B	Zuclopenthixol acetate - 100mg/2ml	100mg/2ml	Injectable solution	857,372 L.L
A10AE04	GLARTUS	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	1,346,530 L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU	10000IU	Injectable solution	4,036,903 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	188,772 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	52,597,003 L.L
A10AE04	LANTUS SOLOSTAR	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	4,992,375 L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU	10,000IU	Injectable solution	10,661,285 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	174,553 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	514,508,612 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	179,063,666 L.L
A10AE04	LANTUS	BioTech	Insulin glargine - 100IU/ml	100IU/ml	Injectable solution	3,327,354 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU/ml	10,000IU/ml	Injectable solution	16,325,433 L.L

National Cancer Registry (NCR)